In January 2025 , Novo Nordisk announced expanded manufacturing capacity for GLP-1 therapies, increasing output by approximately 40% across its global facilities to address rising demand for semaglutide-based obesity and diabetes treatments
CrossRef Effects of caffeoylquinic acid analogs derived from aerial parts of Artemisia iwayomogi on adipogenesis Su-Young Han, Jisu Kim, Bo Kyeong Kim, Wan Kyunn Whang, Hyeyoung Min Food Science and Biotechnology.2023
Take a photo of your vial label and syringe and send it to your provider before you inject
They can track weight and energy markers over time and use direct calorimetry for precise results
Understanding the importance of maintaining digestive health while on GLP-1 medications can empower patients to take proactive steps in managing their overall well-being
Because of this, research has shown that acetyl-L-carnitine helps to protect against aging and neurodegeneration